@inproceedings{2954121,
    title = "Carfilzomib, lenalidomide, and dexamethasone vs lenalidomide and dexamethasone in patients with relapsed multiple myeloma: analysis of response and progression-free survival hazard ratio over time",
    author = "Dimopoulos, MA and Stewart, AK and Wang, M and Maisnar, V and Minarik, J and Bensinger, WI and Mateos, MV and Ben-Yehuda, D and Kukreti, V and Obreja, M and others",
    year = "2016",
    pages = "83--83",
    booktitle = "Haematologica"
}